Neurocrine Biosciences, Inc.
(NASDAQ : NBIX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.69%342.851.2%$619.74m
GILDGilead Sciences, Inc.
-0.80%72.340.9%$506.65m
CELGCelgene Corporation
-0.48%89.941.2%$494.04m
AMGNAmgen Inc.
-0.17%197.091.2%$484.53m
ILMNIllumina, Inc.
0.10%326.213.5%$374.07m
REGNRegeneron Pharmaceuticals, Inc.
-0.53%372.282.6%$314.11m
VRTXVertex Pharmaceuticals Incorporated
-1.06%174.221.9%$206.87m
ALXNAlexion Pharmaceuticals, Inc.
0.07%116.082.0%$186.71m
AAgilent Technologies, Inc.
0.11%64.731.5%$159.45m
SRPTSarepta Therapeutics, Inc.
-0.58%129.5016.6%$141.64m
NKTRNektar Therapeutics
0.23%60.175.6%$126.58m
BLUEBluebird Bio, Inc.
-0.29%157.5514.6%$121.23m
EXASExact Sciences Corporation
-0.85%48.4325.3%$117.82m
BMRNBioMarin Pharmaceutical Inc.
-2.17%98.824.4%$116.17m
INCYIncyte Corporation
-0.39%68.532.5%$111.30m

Company Profile

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.